Article Data

  • Views 1305
  • Dowloads 115

Original Research

Open Access

AGUS and ASCUS: different incidence in pre- and post­ menopausal women

  • G.C. Balbi1,*,
  • A. Cardone1
  • R. Zarcone1
  • G. Visconti1
  • L. Del Piano1

1Department of Gynecology and Obstetrics and Neonatology, II University of Naples (SUN), Naples, Italy

DOI: 10.12892/ejgo200405603 Vol.25,Issue 5,September 2004 pp.603-605

Published: 10 September 2004

*Corresponding Author(s): G.C. Balbi E-mail:

Abstract

Purpose of investigation: The aim of this study was to determine the incidence of AGUS (atypical glandular cells of undetermined significance), ASCUS (atypical squamous cells of undetermined significance) and SIL (squamous intraepithelial lesion) in the cytologic diagnosis in pre- and postmenopausal women.

Methods: We did a retrospective study selecting 183 patients who were screened for cervical pathology. Ninety-six patients were in postmenopausal age. We determined the incidence of cytologic abnormalities defined as ASCUS, SIL, and AGUS in pre- and postmenopausal women.

Results: We expected a marked incidence of low-grade SILs in the fertile population, while the postmenopausal group was thought to be affected more by AGUS and ASCUS. We obtained different results. In our population study, premenopausal women presented more AGUS and ASCUS; the two subgroups presented the same incidence of low-grade SILs; postmenopausal women were more affected by high-grade SILs.

Conclusions: The significance of the new categories introduced by the Bethesda System is still uncertain for different authors. As we look to the future new markers that more specifically identify individuals at-risk can be expected.

Keywords

CIN; Bethesda system; Precancerous lesion

Cite and Share

G.C. Balbi,A. Cardone,R. Zarcone,G. Visconti,L. Del Piano. AGUS and ASCUS: different incidence in pre- and post­ menopausal women. European Journal of Gynaecological Oncology. 2004. 25(5);603-605.

References

[1] Suris J.C., Dexeus S.L.: "Epidemiology of preinvasive lesions" Eur. J. Gynaecol. Oneal., 1999, 4, 20.

[2] Bogdanich W.: "Lax laboratories: the pap test misses much cervical cancer through lab's errors". Wall Street Journal, 1987, 2, 1.

[3] Bogdanich W.: "Physician's carelessness with Pap test is cited in procedure's high failure rate". Wall Street Journal, 1987, 29, 17.

[4] Koss L.G.: "The papanicolau test for cervical cancer detection: a triumph and a tragedy". JAMA, 1989, 261, 737.

[5] Solomon D., Davey D., Kurman R. et al.: "The Bethesda System terminology for reporting results of cervical cytology". JAMA, 2002, 287, 2114.

[6] National Cancer Institute Worshop: "The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses". JAMA, 1989, 262, 931.

[7] Koss L.G.: "The new Bethesda System for reporting results of smears of the uterine cervix". J. Natl. Cancer Inst., 1990, 82, 988.

[8] Richart R.M.: "A modified terminology for cervical intraepithelial neoplasia". Obstet. Gynecol., 1990, 75, 131.

[9] Ronnett B.M., Manos M.M., Ransley J. et al.: "Atypical glandular cells of undetermined significance: cytopathologic features histopathological results, and human papillomavirus DNA detection". Hum. Pathol., 1999, 30, 816.

[10] Kurman R., Malkasian G.D., Sedlis A. et al.: "From Papanicolau to Bethesda: the rationale for a new cervical cytologic classification". Obstet. Gynecol., 1991, 77, 5.

[11] Herrero R., Hildesheima., Bratti C. et al.: "Population study of human papillomavirus infection and cervical neoplasia in rural Costa Rica". J. Natl Cancer Inst., 2000, 15, 92 (6), 464.

[12] Nasuti J.F., Fleisher S.R., Gupta P.K.: "Atypical glandular cells of undetermined significance: cytopathologic features, histopathologic results, and human papillomavirus DNA detection". Hum Pathol., 1999, 30, 816.

[13] Mudu P., Migliore G., Alderisio M. et al.: "Pap-net assisted cytological diagnosis intensifies the already marked variability among cytological laboratories". Eur. J. Gynaecol. Oncol., 2002, 23 (3), 211.

[14] Flynn K., Rimm D.L.: "Diagnosis of'ASCUS'm women over age 50 is less likely to be associated with dysplasia". Diagn. Cytophatol., 2001, 24, 132.

[15] Solomon D., Schiffman M., Tarone R.: "Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial". J. Natl Cancer Inst., 2001, 93, 293.

[16] Robinson W.R., Morris C.B.: "Cervical neoplasia, pathogenesis, diagnosis and management". Hematol. Oncol. of North. Am., 1996, 10, 5.

[17] Chin A.B., Bristow R.E., Korst L.M. et al.:'The significance of atypical glandular cells on routine cervical cytologic testing in a community". Obstet. Gynecol., 2001, 184, 1043.

[18] Ismail S.M., Collclough A.B., Dinnen J.S. et al.: "Reporting cervical intraepithelial neoplasia (CIN): intra- and interpathologists variation and factors associated with disagreement". Histopathology, 1990, 16, 371.

Submission Turnaround Time

Top